Finance & Markets News Today — September 30, 2026

Investors and individuals are navigating a complex landscape of economic and technological developments. On one hand, significant advancements in healthcare are offering new solutions for individuals, as seen in a recent real-world study that found people switching to Novo's Wegovy pill from obesity injections continued to lose weight. This development has implications for the pharmaceutical industry and those seeking innovative treatments.

Meanwhile, major deals are being made in the defense and technology sectors. Boeing saw a 3% rise in its stock after securing a deal with the U.S. Navy to develop a next-generation fighter jet, a move that underscores the company's continued influence in the defense industry. In a separate development, billionaire philanthropist Ken Griffin has pledged $3 billion to Carnegie Mellon University, marking a historic gift to the institution. These stories, along with others, highlight the diverse range of factors influencing markets and individual financial decisions, from career choices and philanthropy to technological innovation and geopolitical tensions.

Today's signal:
• People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study (cnbc.com)
• I’m 71 and still working. I earn $108,000 a year. Am I doing the right thing? (marketwatch.com)
• Ken Griffin pledges $3 billion to Carnegie Mellon University in 'historic' gift (cnbc.com)
• Boeing rises 3% after securing U.S. navy deal to develop next-generation fighter jet (cnbc.com)
• Russia targets data centers in Kyiv as NATO condemns Moscow’s ‘irresponsible nuclear rhetoric’ (cnbc.com)
• Boeing chosen by U.S. navy to develop next-generation fighter jet (cnbc.com)